Re:High genetic barrier to SARS-CoV-2 polyclonal neutralizin...
by IX-103 on Monday September 20, 2021 @09:02PM
(#28600954)
Wait, what? No. Just no.
To confirm efficacy they gave the vaccine to half of a population likely to develop the disease naturally. Then they compared how many people for sick in each group. That's why testing took a year instead of 2 months, they have to wait for enrollees to get sick naturally.
If we ignore ethics, I guess we could get more nuanced efficacy information out of a small sacrificial population. But that is just not done. Not even during a pandemic.
To confirm efficacy they gave the vaccine to half of a population likely to develop the disease naturally. Then they compared how many people for sick in each group. That's why testing took a year instead of 2 months, they have to wait for enrollees to get sick naturally.
If we ignore ethics, I guess we could get more nuanced efficacy information out of a small sacrificial population. But that is just not done. Not even during a pandemic.